| Upper Gastrointestinal Cancer |
| Editorial |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Positron Emission Tomography Scanning in Oesophageal Cancer — Stuck at the First Hurdle?
24 August 2011
Oesophageal cancer remains a poor prognosis disease and most patients present with either locally advanced or metastatic disease, typically with poor functional status, and are unsuitable for aggressi...
|
Stephen Falk
|
83-85
|
|
| Guidelines |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Evidence-based Guideline Recommendations on the use of Positron Emission Tomography Imaging in Oesophageal Cancer
30 September 2011
Abstract: Aims: To provide evidence-based practice guideline recommendations on the use of fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for diagnosis, staging, assessing treatment r...
|
R. Wong,
C. Walker-Dilks,
A. Raifu
|
86-104
|
|
| Original Article |
| |
Article Title |
Author(s) |
Pages |
|
|
|
A Prognostic Model to Identify Patients with Advanced Pancreas Adenocarcinoma Who Could Benefit from Second-line Chemotherapy
08 March 2011
Abstract: Aims: The role of salvage chemotherapy after first-line therapy in advanced pancreatic cancer has not yet been established. We intended to identify prognostic factors for long-term survival ...
|
Seung Tae Kim,
Yoon Ji Choi,
Kyong Hwa Park,
Sang Cheul Oh,
Jae Hong Seo,
Sang Won Shin,
Jun Suk Kim,
Yeul Hong Kim
et al.
|
105-111
|
|
| Pelvic Radiotherapy |
| Original Articles |
| |
Article Title |
Author(s) |
Pages |
|
|
|
A Randomised Double-blind Placebo-controlled Trial to Determine the Effect of Cranberry Juice on Decreasing the Incidence of Urinary Symptoms and Urinary Tract Infections in Patients Undergoing Radiotherapy for Cancer of the Bladder or Cervix
23 June 2011
Abstract: Aims: Radical pelvic radiotherapy is one of the main treatment modalities for cancers of the bladder and cervix. The side-effects of pelvic radiotherapy include urinary symptoms, such as uri...
|
C.C. Cowan,
C. Hutchison,
T. Cole,
S.J.E. Barry,
J. Paul,
N.S. Reed,
J.M. Russell
et al.
|
e31-e38
|
|
|
|
Evaluation of Set-up Uncertainties with Daily Kilovoltage Image Guidance in External Beam Radiation Therapy for Gynaecological Cancers
26 September 2011
Abstract: Aims: To assess the set-up uncertainty for gynaecological cancer patients treated with external beam radiation therapy using daily kilovoltage image guidance and to estimate set-up margins f...
|
H. Kim,
S. Beriwal,
M.S. Huq,
N. Kannan,
G. Shukla,
C. Houser
et al.
|
e39-e45
|
|
| Lung Cancer |
| Original Article |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Mapping Use of Radiotherapy for Patients with Non-small Cell Lung Cancer in the Netherlands between 1997 and 2008
22 July 2011
Abstract: Aim: After the publication of several reports that the utilisation rate of radiotherapy for patients with non-small cell lung cancer (NSCLC) varies for both medical and non-medical reasons, ...
|
C.C.E. Koning,
M.J. Aarts,
H. Struikmans,
P.M.P. Poortmans,
M.L.M. Lybeert,
J.J. Jobsen,
J.W.W. Coebergh,
M.L.G. Janssen-Heijnen,
O. Visser,
W.J. Louwman,
J.A. Burgers
et al.
|
e46-e53
|
|
| Palliative Radiotherapy |
| Original Articles |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Update on the Systematic Review of Palliative Radiotherapy Trials for Bone Metastases
30 November 2011
Abstract: Aims: To update previous meta-analyses of randomised palliative radiotherapy trials comparing single fractions versus multiple fractions. Materials and methods: All published randomised cont...
|
E. Chow,
L. Zeng,
N. Salvo,
K. Dennis,
M. Tsao,
S. Lutz
et al.
|
112-124
|
|
|
|
Assessment of Health-related Quality of Life with the European Organization for Research and Treatment of Cancer QLQ-C15-PAL after Palliative Radiotherapy of Bone Metastases
14 September 2011
Abstract: Aims: To assess health-related quality of life (HRQOL) after palliative radiotherapy for painful bone metastases using a palliative questionnaire (European Organization for Research and Trea...
|
A. Caissie,
L. Zeng,
J. Nguyen,
L. Zhang,
F. Jon,
K. Dennis,
L. Holden,
S. Culleton,
K. Koo,
M. Tsao,
E. Barnes,
C. Danjoux,
A. Sahgal,
C. Simmons,
E. Chow
et al.
|
125-133
|
|
|
|
A Survey of Expectations and Understanding of Palliative Radiotherapy from Patients with Advanced Cancer
03 October 2011
Abstract: Aims: : To assess patients’ understanding of their illness and expectations of palliative radiotherapy for symptomatic metastases before and after consultation and to explore the relationshi...
|
G. Mitera,
L. Zhang,
A. Sahgal,
E. Barnes,
M. Tsao,
C. Danjoux,
L. Holden,
E. Chow
et al.
|
134-138
|
|
|
|
Frequency of Reporting and Predictive Factors for Anxiety and Depression in Patients with Advanced Cancer
08 June 2011
Abstract: Aims: The prevalence of anxiety and depression in patients with advanced cancer has been reported to be on average 25% and to significantly affect patients’ quality of life. Despite high pre...
|
N. Salvo,
L. Zeng,
L. Zhang,
M. Leung,
L. Khan,
R. Presutti,
J. Nguyen,
L. Holden,
S. Culleton,
E. Chow
et al.
|
139-148
|
|
| Letters |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Treatment of Glioblastoma Multiforme — The Oxford Cancer Centre Experience
10 November 2011
Sir — Glioblastoma multiforme (GBM) is an aggressive primary brain tumour. In 2005, a landmark European Organization for Research and Treatment of Cancer/National Cancer Institute Canada (EORTC/NCIC) ...
|
A. Medisetti,
R. Jampana,
N. Warner,
C. Blesing
|
149-150
|
|
|
|
Radiotherapy and Cervix Cancer — University Hospitals Birmingham Experience with Patients Not Suitable for Concurrent Chemoradiotherapy with Cisplatin
11 November 2011
Sir — The most effective treatment for patients with cervical cancer is concurrent chemoradiotherapy using cisplatin . However, this is not suitable for all patients. Over 5 years, 74 patients in our ...
|
E. Beaumont,
I.N. Fernando
|
150-151
|
|
| Abstracts |
| |
Article Title |
Author(s) |
Pages |
|
|
|
The Role of mp-MRI in the Detection of Prostate Cancer
Introduction: Multi-parametric MRI (mp-MRI) has the potential to serve as a non-invasive triage test for men at risk of prostate cancer. We present a preliminary analysis of a paired dataset in which ...
|
M. Abd Alazeez,
H. Ahmed,
C. Moore,
A. Kirkham,
A. Freeman,
M. Emberton
et al.
|
154
|
|
|
|
Single Fraction HDR Boost and Dose Escalation for Intermediate and High Risk Prostate Cancer. A Report of Toxicity from a Single Centre Experience
Introduction: High dose rate (HDR) brachytherapy, delivered with hypofractionated external beam radiotherapy (EBRT), enables dose escalation with improvements in tumour control and rates of biochemica...
|
C. Arthur,
P. Mandall,
R. Swindell,
J.P. Logue,
J.P. Wylie
et al.
|
154
|
|
|
|
Pelvic External Beam Radiotherapy and High Dose Rate Image Guided Interstitial Brachytherapy Boost for High Risk Prostate Cancer
Introduction: Evaluation of pelvic nodal external beam radiotherapy (EBRT) with interstitial high dose rate brachytherapy (HDRB) boost to prostate and seminal vesicles for high risk prostate adenocarc...
|
P. De Ieso,
U. Schick,
D. Ward,
R. Hughes,
P. Ostler,
P. Hoskin
et al.
|
154-155
|
|
|
|
Acute Toxicity Rates in Patients Receiving Salvage Radical Prostate Irradiation Following Primary High Intensity Focused Ultrasound (HIFU) for Localised Prostate Cancer
Introduction: HIFU is used in the treatment of primary prostate cancer. It aims to achieve cancer control while offering a potentially more favourable toxicity profile [1]. Long term randomised data a...
|
A. Aggarwal,
R. Davda,
M. Emberton,
H. Payne
|
155
|
|
|
|
Multi-institutional Outcome Following LDR Brachytherapy in Patients with Higher Risk Prostate Cancer
Introduction: We report the outcomes for a cohort of men with higher risk prostate adenocarcinoma treated with LDR brachytherapy in a multi-institutional UK practice.
|
R. Conroy,
P. Hoskin,
D. Bottomley,
P. Mandall,
R. Swindell,
J. Wylie
et al.
|
155
|
|
|
|
Sunitinib Malate in the Treatment of Metastatic Renal Cell Carcinoma: the North of England Cancer Network (NECN) Experience
Introduction: Metastatic renal cell carcinoma (mRCC) has a poor prognosis. Treatment aims to improve progression free survival (PFS) and overall survival (OS). Sunitinib gained NICE approval in March ...
|
R.A. Goranova,
B.B. Goranov,
I.D. Pedley,
A. Azzabi,
A. Humphreys,
R. McMenemin,
J.A. Frew
et al.
|
155
|
|
|
|
Intensity Modulated Radiotherapy (IMRT) in the Treatment of Pelvic Lymph Nodes in Locally Advanced Prostate Cancer (LAPCa): a Single UK Institution Experience
Introduction: Evidence is in favour of localised radiotherapy in the treatment of LAPCa. Whether there is added disease control by including the pelvic lymph nodes in the irradiation volume is less cl...
|
M. Hadaki,
H.V. Janes,
R. Venkitaraman,
C.D. Scrase
|
156
|
|
|
|
Analysis of Malignant Spinal Cord Compression Patients treated in a Regional Neuro-oncology Centre
Introduction: Since December 2009 there has been a spinal cord compression coordinator in the Lancashire and Cumbria cancer network to enable patients to receive care as per NICE 2008 guidelines [1]. ...
|
S. Kennedy,
J. Law,
G. Skailes,
A. Birtle
|
156
|
|
|
|
Radical Radiotherapy for Localised Hormone Refractory Prostate Cancer
Introduction: Since PR07 and the Scandinavian Prostate Cancer Group showed survival benefit from adding radical radiotherapy (RT) to androgen deprivation therapy, prostate RT is routinely offered to f...
|
A. Pascoe,
S. Sundar
|
156
|
|
|
|
Clinical Outcomes of a Phase II Open-labelled, Randomised Study Investigating the Tolerability and Efficacy of Anti-androgen Manipulation versus Taxotere and Anti-androgen Manipulation in Patients with Hormone Naive High Risk/Metastatic Prostate Cancer
Introduction: Androgen ablation (AA) is considered the standard initial therapy for men with high risk/metastatic prostate cancer. The role of chemotherapy and androgen ablation (TAA) is still undefin...
|
J. Wilson,
A.B. Al-Naeeb,
A.R.A. Razak,
J.A. Frew,
A. Azzabi,
R. McMenemin,
N. Soomro,
G. Durkan,
H. Leung,
I.D. Pedley
et al.
|
156-157
|
|
|
|
Meetings Notice
|
|
I
|
|
